The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) has come to its end on 31 January 2019. HA-REACT had 22 partners, representing 18 EU Member States, with additional expertise provided by 14 collaborating partners, including the...
Every second person diagnosed with HIV has already reached an advanced stage in the infection – which is one reason for a persistent HIV epidemic in Europe This shows that reaching and testing those at risk of infection with HIV is still a public health...
The EU has published a staff working document on combatting HIV/AIDS, viral hepatitis B and C and tuberculosis in the European Union and neighbouring countries. These diseases pose the greatest risk to populations that are often also socially marginalised, such as...
Based on data reported to ECDC between 2004 and 2015, 312 501 new HIV diagnoses were reported in younger adults (15 to 49 years of age) in the EU/EEA, resulting in an average reported incidence of new diagnoses of 11.4 per 100 000 population. During this 12-year...
The World Health Organization (WHO) HIV drug resistance report 2017 shows that of the 36.7 million people living with HIV worldwide, 19.5 million people were accessing anti-retroviral therapy in 2016. The majority of these people are doing well, with treatment proving...
